Global Drugs For Herpes Labialis (Oral Herpes) Market Study 2015-2025, by Segment (Valacyclovir, Aciclovir, Famciclovir), by Market (External Use, OralAciclovir, Injection), by Company (GSK, Novartis, Teva)
ReportPage
Report ID
49033
Published Date
20-Sep
No of Report Page
83
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details 
    Snapshot
    
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2?3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic peo
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Drugs For Herpes Labialis (Oral Herpes) Industry
    
        1.1.1 Overview
    
        1.1.2 Products of Major Companies
    
    1.2 Market Segment
    
        1.2.1 Industry Chain
    
        1.2.2 Consumer Distribution
    
    1.3 Price & Cost Overview
    
2 Drugs For Herpes Labialis (Oral Herpes) Market by Type
    
    2.1 By Type
    
       2.1.1 Valacyclovir
    
       2.1.2 Aciclovir
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -